Amarin Corp: Q3 Earnings Insights


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Shares of Amarin Corp (NASDAQ: AMRN) fell 0.2% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were down 100.00% over the past year to ($0.02), which missed the estimate of $0.01.

Revenue of $156,499,000 up by 39.22% year over year, which beat the estimate of $154,630,000.

Outlook

Amarin Corp hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

How To Listen To The Conference Call

Date: Nov 05, 2020

Time: 07:30 AM

ET Webcast URL: https://www.webcaster4.com/Webcast/Page/2037/38230

Recent Stock Performance

Company's 52-week high was at $26.12

Company's 52-week low was at $3.36

Price action over last quarter: down 27.41%

Company Overview

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its products include Vascepa.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Earnings